Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 199 | 419 | 496 | 40 | 223 |
| Receivables | 194 | 211 | 308 | 395 | 285 |
| Inventories | 354 | 354 | 203 | 10 | 10 |
| TOTAL | $779 | $1,043 | $1,041 | $682 | $647 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 1 | 1 | 2 |
| Intangibles | 1,850 | 1,854 | 1,830 | 1,798 | 1,738 |
| TOTAL | $1,850 | $1,855 | $1,831 | $1,799 | $1,739 |
| Total Assets | $2,628 | $2,898 | $2,872 | $2,481 | $2,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | 358 | N/A | N/A | N/A |
| Accrued Expenses | N/A | 193 | N/A | N/A | N/A |
| TOTAL | $725 | $917 | $884 | $1,138 | $878 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 440 | 366 | 347 | 399 | 283 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $725 | $917 | $884 | $1,138 | $878 |
| Shareholders' Equity | |||||
| Common Shares | 6,108 | 5,695 | 5,836 | 5,262 | 5,262 |
| Retained earnings | -5,435 | -4,956 | -4,732 | -4,318 | -4,096 |
| Other shareholders' equity | 381 | 381 | 266 | 0 | 0 |
| TOTAL | $1,904 | $1,981 | $1,988 | $1,343 | $1,509 |
| Total Liabilities And Equity | $2,628 | $2,898 | $2,872 | $2,481 | $2,387 |